| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |